Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Mocking someone's name to get your point across is childish

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Apr 07, 2021 1:30pm

140 Views

Post# 32950226

RE:RE:RE:RE:RE:Mocking someone's name to get your point across is childish

Metals to be frank the reason I'm still in this play is for a licensing deal. I feel this catalyst is worth holding for. Bought deal is the cogs of venture capital doing its thing. Seronva was a bit early to the game and faced challenges with raising capital in a fringe market but RM is taking off and the game is changing so I'm not looking to the past for answers to the future. Seasonality in markets these days doesn't mean much.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles